CMX001
CMX001-106
Phase 1 small_molecule completed
Quick answer
CMX001 for Hepatic Impairment is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Hepatic Impairment
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed